Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis
ABSTRACTBackground Galectin (Gal) is considered a promising immune checkpoint molecule. More and more studies have shown that high expression levels of galectins in hematologic cancer are positively correlated with poor clinical prognosis. However, the exact prognostic significance of galectins rema...
Main Authors: | Haotian Liu, Qiuying Dai, Yixian Li, Zhenfei Tang, Tiantian She |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Hematology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2023.2227494 |
Similar Items
-
Galectins can serve as biomarkers in COVID-19: A comprehensive systematic review and meta-analysis
by: Amir Hossein Behnoush, et al.
Published: (2023-02-01) -
Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
by: Fei Kong, et al.
Published: (2020-09-01) -
Galectin-3 is associated with the functional outcome and mortality in stroke patients: A systematic review and meta-analysis
by: Xiaoling Han, et al.
Published: (2023-02-01) -
Prevalence and prognostic value of baseline sarcopenia in hematologic malignancies: a systematic review
by: Xiaofeng Zeng, et al.
Published: (2023-12-01) -
Role of Galectins in Multiple Myeloma
by: Paola Storti, et al.
Published: (2017-12-01)